Fortescue trades at A$19.84 versus fair value A$26.47 (33% upside), with 2.4x EV/EBITDA at 41% discount to peers despite industry-leading C1 costs US$17.99/wmt and 0.14x net debt-to-EBITDA.
View noteBUY rating with $17.07 fair value vs $12.38 current price. Strong Australian market position, successful operational transformation, 38% upside potential over 18-24 months.
View noteFair value $0.84 vs current $0.72. 22% EBITDA margins, 72% government funding, 13% revenue growth. Consolidation platform in fragmented market.
View noteHOLD rating with $28.34 fair value vs $27.04 current price. Market leader in independent trustee services with 8.3% FCF yield, though regulatory overhang and fee compression limit upside.
View noteSTRONG SELL rating with 84% downside to $2.20 fair value. EBITDA margins compressing from 26.4% peak as competition intensifies.
View noteQuality gold producer with US$1,075/oz AISC trading at A$4.11 vs A$2.71 fair value. Strong operations, excessive valuation, 34% overvalued.
View noteMarket leader trading at 48% discount to peers despite regulatory moats. Fair value $5.02 vs current $4.18 with 20% upside potential.
View noteSELL rating with fair value $18.62 vs current $30.24. Healthcare distribution leader faces margin compression and direct distribution threats.
View noteSELL rating with fair value $4.71 vs current $7.42. Office REIT facing structural headwinds from hybrid working, 64% downside risk.
View noteHOLD rating with $2.39 fair value vs $2.80 current price. Exceptional 98.6% occupancy offset by development execution risks and overvaluation concerns.
View noteREDUCE rating with $5.50 target vs $9.06 current. Fair value $5.07 implies 44% downside. 71% ROIC, debt-free balance sheet offset by Microsoft dependency and margin compression.
View noteInfrastructure services leader trading at $6.89 vs $9.78 fair value following successful transformation. EBITDA margins at 10-year highs, 42% upside potential.
View note